{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:43:13Z","timestamp":1794069793051,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.phymed.2021.153488","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T09:46:50Z","timestamp":1612086410000},"page":"153488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGF\u03b2\/Smad2 pathway"],"prefix":"10.1016","volume":"83","author":[{"given":"Yaping","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phymed.2021.153488_bib0001","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2337\/db13-1830","article-title":"Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice","volume":"63","author":"Abdo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2021.153488_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phymed.2018.03.034","article-title":"Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-beta-mediated Smad3 phosphorylation","volume":"42","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2021.153488_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.fitote.2011.09.014","article-title":"Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells","volume":"83","author":"Chen","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phymed.2021.153488_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/DDDT.S151660","article-title":"The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation","volume":"12","author":"Chen","year":"2018","journal-title":"Drug Des Devel Ther."},{"issue":"12","key":"10.1016\/j.phymed.2021.153488_bib0005","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s12272-015-0626-3","article-title":"Anti-adipogenic effect of epiberberine is mediated by regulation of the Raf\/MEK1\/2\/ERK1\/2 and AMPKalpha\/Akt pathways","volume":"38","author":"Choi","year":"2015","journal-title":"Arch Pharm Res"},{"issue":"12","key":"10.1016\/j.phymed.2021.153488_bib0006","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrendo.2013.184","article-title":"Diabetic nephropathy: diagnosis and treatment","volume":"9","author":"Fineberg","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.phymed.2021.153488_bib0007","article-title":"The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases","volume":"8","author":"Habtemariam","year":"2020","journal-title":"Physicochemical Modification Approaches. Biomedicines."},{"issue":"10","key":"10.1016\/j.phymed.2021.153488_bib0008","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.phymed.2021.153488_bib0009","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0035-1568261","article-title":"Hypolipidemic Effects of Alkaloids from Rhizoma Coptidis in Diet-Induced Hyperlipidemic Hamsters","volume":"82","author":"He","year":"2016","journal-title":"Planta Med"},{"issue":"4","key":"10.1016\/j.phymed.2021.153488_bib0010","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/molecules25040950","article-title":"Contribution of TGF-\u03b21 and Effects of Gene Silencer Pyrrole-Imidazole Polyamides Targeting TGF-\u03b21 in Diabetic Nephropathy","volume":"25","author":"Horikoshi","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.phymed.2021.153488_bib0011","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1248\/bpb.32.1433","article-title":"Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids","volume":"32","author":"Jung","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.phymed.2021.153488_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2052180","article-title":"Antioxidant and Anti-Inflammatory Effects of Rhei Rhizoma and Coptidis Rhizoma Mixture on Reflux Esophagitis in Rats","volume":"2016","author":"Kwon","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.phymed.2021.153488_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104320","article-title":"Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway","volume":"146","author":"Lei","year":"2019","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.phymed.2021.153488_bib0014","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1080\/15548627.2016.1190071","article-title":"Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2\/M arrest and renal fibrosis","volume":"12","author":"Li","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2021.153488_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13020-016-0075-z","article-title":"Chinese medicines in the treatment of experimental diabetic nephropathy","volume":"11","author":"Liu","year":"2016","journal-title":"Chin Med"},{"key":"10.1016\/j.phymed.2021.153488_bib0016","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3389\/fphar.2019.00538","article-title":"Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II\/Transformation Growth Factor beta1 Fibrogenic Axis","volume":"10","author":"Liu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.phymed.2021.153488_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.fitote.2019.03.003","article-title":"The anti-hyperglycemia effects of Rhizoma Coptidis alkaloids: A systematic review of modern pharmacological studies of the traditional herbal medicine","volume":"134","author":"Ma","year":"2019","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.phymed.2021.153488_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ddr.21302","article-title":"Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice","volume":"77","author":"Ma","year":"2016","journal-title":"Drug Dev Res"},{"issue":"7","key":"10.1016\/j.phymed.2021.153488_bib0019","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/ijms21072632","article-title":"Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities","volume":"21","author":"Opazo-R\u00edos","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.phymed.2021.153488_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.kisu.2017.10.003","article-title":"Diagnosis of diabetic kidney disease: state of the art and future perspective","volume":"8","author":"Persson","year":"2018","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.phymed.2021.153488_bib0021","first-page":"120","article-title":"Histological changes of kidney in diabetic nephropathy","volume":"6","author":"Pourghasem","year":"2015","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.phymed.2021.153488_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/med.21703","article-title":"Biologically active isoquinoline alkaloids covering 2014-2018","author":"Shang","year":"2020","journal-title":"Med Res Rev."},{"issue":"6","key":"10.1016\/j.phymed.2021.153488_bib0023","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/med.21703","article-title":"Biologically active isoquinoline alkaloids covering 2014-2018","volume":"40","author":"Shang","year":"2020","journal-title":"Med Res Rev"},{"issue":"2","key":"10.1016\/j.phymed.2021.153488_bib0024","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrneph.2010.156","article-title":"Effects of polyunsaturated fatty acid consumption in diabetic nephropathy","volume":"7","author":"Shapiro","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.phymed.2021.153488_bib0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.redox.2017.06.009","article-title":"The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats","volume":"13","author":"Steven","year":"2017","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.phymed.2021.153488_bib0026","doi-asserted-by":"crossref","first-page":"e13190","DOI":"10.1111\/apha.13190","article-title":"Klotho protein supplementation reduces blood pressure and renal hypertrophy in db\/db mice, a model of type 2 diabetes","volume":"225","author":"Takenaka","year":"2019","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.phymed.2021.153488_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2017.02.004","article-title":"Epiberberine, a natural protoberberine alkaloid, inhibits urease of Helicobacter pylori and jack bean: Susceptibility and mechanism","volume":"110","author":"Tan","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.phymed.2021.153488_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41581-020-0260-2","article-title":"Targeting angiogenesis and lymphangiogenesis in kidney disease","volume":"16","author":"Tanabe","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.phymed.2021.153488_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/jphp.12677","article-title":"Tetrahydrobiopterin contributes to the proliferation of mesangial cells and accumulation of extracellular matrix in early-stage diabetic nephropathy","volume":"69","author":"Wang","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.phymed.2021.153488_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.phymed.2017.10.008","article-title":"Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-beta\/Smad signaling pathway","volume":"36","author":"Wang","year":"2017","journal-title":"Phytomedicine"},{"issue":"18","key":"10.1016\/j.phymed.2021.153488_bib0031","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1039\/C6CP01555G","article-title":"Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power","volume":"18","author":"Wang","year":"2016","journal-title":"Phys Chem Chem Phys"},{"issue":"7","key":"10.1016\/j.phymed.2021.153488_bib0032","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14728222.2019.1624721","article-title":"Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies","volume":"23","author":"Warren","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"7740","key":"10.1016\/j.phymed.2021.153488_bib0033","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","article-title":"Human blood vessel organoids as a\u00a0model of\u00a0diabetic vasculopathy","volume":"565","author":"Wimmer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2021.153488_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phymed.2018.04.031","article-title":"Carnosic acid improves diabetic nephropathy by activating Nrf2\/ARE and inhibition of NF-\u03baB pathway","volume":"47","author":"Xie","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153488_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1839809","article-title":"Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective","volume":"2017","author":"Xue","year":"2017","journal-title":"J Diabetes Res"},{"issue":"5","key":"10.1016\/j.phymed.2021.153488_bib0036","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/dc18-1320","article-title":"Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study","volume":"42","author":"Yamanouchi","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.phymed.2021.153488_bib0037","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jep.2012.10.062","article-title":"Safety evaluation of main alkaloids from Rhizoma Coptidis","volume":"145","author":"Yi","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.phymed.2021.153488_bib0038","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3892\/ijmm.2020.4647","article-title":"Inhibition of miRNA-135a-5p ameliorates TGF-\u03b21-induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy","volume":"46","author":"Zhang","year":"2020","journal-title":"Int J Mol Med"},{"issue":"11","key":"10.1016\/j.phymed.2021.153488_bib0039","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-019-2085-0","article-title":"Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice","volume":"10","author":"Zheng","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.phymed.2021.153488_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.11.017","article-title":"Epiberberine reduces serum cholesterol in diet-induced dyslipidemia Syrian golden hamsters via network pathways involving cholesterol metabolism","volume":"774","author":"Zou","year":"2016","journal-title":"Eur J Pharmacol"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:25:53Z","timestamp":1760552753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"alternative-id":["S0944711321000301"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153488","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGF\u03b2\/Smad2 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153488"}}